Literature DB >> 30224324

Efficacy data in treatment extension studies of idiopathic pulmonary fibrosis: interpret with caution.

Athol U Wells1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30224324     DOI: 10.1016/S2213-2600(18)30385-0

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  2 in total

1.  Pirfenidone improves survival in IPF: results from a real-life study.

Authors:  George A Margaritopoulos; Athina Trachalaki; Athol U Wells; Eirini Vasarmidi; Eleni Bibaki; George Papastratigakis; Stathis Detorakis; Nikos Tzanakis; Katerina M Antoniou
Journal:  BMC Pulm Med       Date:  2018-11-23       Impact factor: 3.317

2.  Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study.

Authors:  Katerina Antoniou; Katerina Markopoulou; Argyrios Tzouvelekis; Athina Trachalaki; Eirini Vasarmidi; Jiannis Organtzis; Vasilios Tzilas; Evangelos Bouros; Georgia Kounti; Christina Rampiadou; Serafeim-Chrysovalantis Kotoulas; Fotini Bardaka; Eleni Bibaki; Evangelia Fouka; Georgios Meletis; Stavros Tryfon; Zoe Daniil; Despina Papakosta; Demosthenes Bouros
Journal:  ERJ Open Res       Date:  2020-01-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.